Annie Talbot

Positive Care Clinic

  • 3351 El Camino Real
  • Atherton, CA 94027
  • Phone: 650-723-9001
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Family Medicine, American Board of Family Medicine (2009)

Residency: University of Sherbrooke (1999) Canada

Medical Education: University of Montreal (1997) Canada

Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis
Bendavid, E., Grant, P., Talbot, A., Owens, D. K., & Zolopa, A. (2011). Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis. AIDS, 25(2), 211-220.

Predicting Tipranavir and Darunavir Resistance Using Genotypic, Phenotypic, and Virtual Phenotypic Resistance Patterns: an Independent Cohort Analysis of Clinical Isolates Highly Resistant to All Other Protease Inhibitors
Talbot, A., Grant, P., Taylor, J., Baril, J.-G., Liu, T. F., & Zolopa, A. (2010). Predicting Tipranavir and Darunavir Resistance Using Genotypic, Phenotypic, and Virtual Phenotypic Resistance Patterns: an Independent Cohort Analysis of Clinical Isolates Highly Resistant to All Other Protease Inhibitors. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 54(6), 2473-2479.

Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: Effects on level of residual viremia and quality of life
Grant, P. M., Palmer, S., Bendavid, E., Talbot, A., Slamowitz, D. C., & Zolopa, A. R. (2009). Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: Effects on level of residual viremia and quality of life. JOURNAL OF CLINICAL VIROLOGY, 46(4), 305-308.

Switch from Enfuvirtide to Raltegravir in patients with indetectable viral load: Efficacy and safety at 24 weeks in a Montreal Cohort
Annie Talbot, N Machouf, R Thomas, S Marcotte, R Therrien, & R Lalonde. (2009). Switch from Enfuvirtide to Raltegravir in patients with indetectable viral load: Efficacy and safety at 24 weeks in a Montreal Cohort. JAIDS, 51(3).

Acute renal failure in 4 HIV-Infected patients: potential association with Tenofovir and ARVs
Suzanne Marcotte, A Talbot, & B Trottier. (2008). Acute renal failure in 4 HIV-Infected patients: potential association with Tenofovir and ARVs. Canadian Journal of Infectious Disease and Medical Microbiology, 19(1).

La prise en charge et le traitement des personnes co-infectées par le virus de l?immunodéficience humaine (VIH) et de l?hépatite B (VHB)
Jean-Guy Baril, MA Charron, C Fortin, M Klein, R Lalonde, & JP Villeneuve P. Wong. (2008). La prise en charge et le traitement des personnes co-infectées par le virus de l?immunodéficience humaine (VIH) et de l?hépatite B (VHB). Guide pour les professionnels de la santé du Québec, 1(1).